Strive Financial Group’s Cellebrite CLBT Stock Holding History

Strive Financial Group’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-275	Closed	-$4K	–	869
2026 Q1	$4K	Buy	+275	New	+$4.14K	﹤0.01%	540

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Strive Financial Group's CLBT Position: Q2 2026 in Review

Strive Financial Group sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 275 shares — an estimated $4K sold.

Strive Financial Group first reported a position in CLBT in Q1 2026 and held it in 1 quarter. The position peaked at $4K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Strive Financial Group reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
Strive Financial Group sold 275 Cellebrite shares in Q2 2026, an estimated $4K.
Strive Financial Group first reported a position in Cellebrite in Q1 2026 and held it in 1 quarter.
Strive Financial Group's Cellebrite position peaked at $4K in Q1 2026.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.